
Trump's HIV funding cuts leave treatment steady but prevention and data reporting falter
Official data show PEPFAR kept about 20 million people on HIV treatment in mid-2025, but prevention work deteriorated sharply: roughly 4 million fewer people were tested in Q4 2025, new treatment starts fell, PrEP enrollments dropped about 41%, and prevention programs for key populations collapsed to near zero, all amid workforce cuts and less transparent reporting—raising concerns of a hidden, long-term HIV surge despite seemingly steady treatment numbers.











